Oak Thistle LLC Purchases New Stake in Doximity, Inc. (NASDAQ:DOCS)

Oak Thistle LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,004 shares of the company’s stock, valued at approximately $323,000.

A number of other large investors have also recently made changes to their positions in the business. Creative Financial Designs Inc. ADV raised its position in Doximity by 16.7% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after buying an additional 473 shares during the last quarter. Treasurer of the State of North Carolina lifted its position in shares of Doximity by 1.0% during the fourth quarter. Treasurer of the State of North Carolina now owns 53,128 shares of the company’s stock valued at $1,490,000 after purchasing an additional 520 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in Doximity by 111.3% during the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock worth $28,000 after purchasing an additional 524 shares during the last quarter. Linden Thomas Advisory Services LLC grew its position in Doximity by 2.0% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 40,758 shares of the company’s stock worth $1,143,000 after purchasing an additional 793 shares in the last quarter. Finally, Arizona State Retirement System increased its stake in Doximity by 2.6% in the 4th quarter. Arizona State Retirement System now owns 31,950 shares of the company’s stock valued at $896,000 after buying an additional 801 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. William Blair restated an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. Needham & Company LLC restated a “hold” rating on shares of Doximity in a research note on Friday, May 17th. Morgan Stanley reaffirmed an “underweight” rating and set a $25.00 target price on shares of Doximity in a research report on Tuesday, April 23rd. JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price target on the stock in a report on Thursday, April 25th. Finally, Evercore ISI raised their price objective on shares of Doximity from $28.00 to $29.00 and gave the stock an “in-line” rating in a report on Friday, May 17th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Doximity currently has an average rating of “Hold” and an average target price of $28.73.

Check Out Our Latest Analysis on DOCS

Insider Activity at Doximity

In related news, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $30.00, for a total transaction of $900,000.00. Following the sale, the chief financial officer now owns 288,685 shares of the company’s stock, valued at approximately $8,660,550. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Craig Overpeck sold 1,500 shares of the business’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.85, for a total transaction of $35,775.00. Following the completion of the transaction, the insider now owns 108,609 shares of the company’s stock, valued at $2,590,324.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $30.00, for a total transaction of $900,000.00. Following the completion of the transaction, the chief financial officer now owns 288,685 shares in the company, valued at $8,660,550. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 44,000 shares of company stock valued at $1,303,825. Corporate insiders own 39.40% of the company’s stock.

Doximity Price Performance

Doximity stock opened at $27.48 on Tuesday. The firm has a market capitalization of $5.10 billion, a P/E ratio of 36.33, a PEG ratio of 5.23 and a beta of 1.22. Doximity, Inc. has a one year low of $19.71 and a one year high of $36.29. The business has a fifty day moving average price of $26.70 and a 200-day moving average price of $27.49.

Doximity (NASDAQ:DOCSGet Free Report) last issued its earnings results on Thursday, May 16th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. Doximity had a return on equity of 17.44% and a net margin of 31.04%. The business had revenue of $118.06 million during the quarter, compared to the consensus estimate of $116.46 million. Sell-side analysts expect that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.